These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 13792016

  • 1. Tranylcypromine in depression: a clinical report.
    AGIN HV.
    Am J Psychiatry; 1960 Aug; 117():150-1. PubMed ID: 13792016
    [No Abstract] [Full Text] [Related]

  • 2. Tranylcypromine (Parnate) in the ambulatory treatment of depressed patients.
    LURIE ML, SALZER HM.
    Am J Psychiatry; 1961 Aug; 118():152-5. PubMed ID: 13764412
    [No Abstract] [Full Text] [Related]

  • 3. Tranylcypromine in the office treatment of depression.
    PELZMAN O.
    Psychiatr Q; 1961 Apr; 35():261-7. PubMed ID: 13734049
    [No Abstract] [Full Text] [Related]

  • 4. The use of Parnate in the treatment of depression.
    MILLER MH.
    Am J Psychiatry; 1961 Nov; 118():454-5. PubMed ID: 14474076
    [No Abstract] [Full Text] [Related]

  • 5. Trifluoperazine and Tranylcypromine in chronic refractory schizophrenics.
    KRUSE W.
    Am J Psychiatry; 1960 Dec; 117():548-9. PubMed ID: 13754637
    [No Abstract] [Full Text] [Related]

  • 6. Tranylcypromine (parnate) a new monoamine oxidase inhibitor.
    LEMERE F.
    Am J Psychiatry; 1960 Sep; 117():249. PubMed ID: 14415582
    [No Abstract] [Full Text] [Related]

  • 7. Combined use of tranylcypromine and trifluoperazine in ambulatory treatment of patients with agitated depressions: Preliminary evaluation.
    LESSE S.
    N Y State J Med; 1961 Jun 01; 61():1898-903. PubMed ID: 13761180
    [No Abstract] [Full Text] [Related]

  • 8. A clinical trial of an antidepressant, tranylcy-promine ("Parnate").
    KINGSTON WR.
    Med J Aust; 1962 Jun 30; 49(1)():1011-2. PubMed ID: 14456153
    [No Abstract] [Full Text] [Related]

  • 9. Some pharmacological observations on tranylcypromine (SKF trans-385), a potent inhibitor of monoamine oxidase.
    TEDESCHI RE, TEDESCHI DH, AMES PL, COOK L, MATTIS PA, FELLOWS EJ.
    Proc Soc Exp Biol Med; 1959 Nov 30; 102():380-1. PubMed ID: 13837261
    [No Abstract] [Full Text] [Related]

  • 10. The effect of tranylcypromine-trifluoperazine in the treatment of depressive states.
    BRAM G.
    Can Psychiatr Assoc J; 1962 Nov 30; 7(Suppl)():84-6. PubMed ID: 13872435
    [No Abstract] [Full Text] [Related]

  • 11. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H, SAWYER JL.
    J Pharmacol Exp Ther; 1960 Jul 30; 129():243-9. PubMed ID: 13851489
    [No Abstract] [Full Text] [Related]

  • 12. The use of tranylcypromine and trifluoperazine in the management of coexisting depression and anxiety.
    GODDARD ES.
    Can Psychiatr Assoc J; 1962 Jul 30; 7(Suppl)():87-90. PubMed ID: 13899397
    [No Abstract] [Full Text] [Related]

  • 13. Combined tranylcypromine-trifluoperazine therapy in the treatment of patients with agitated depressions.
    LESSE S.
    Am J Psychiatry; 1961 May 30; 117():1038-9. PubMed ID: 13761179
    [No Abstract] [Full Text] [Related]

  • 14. The relative merits of tranylcypromine alone and tranylcypromine in combination with trifluoperazine in the treatment of patients with severe agitated depressions.
    LESSE S.
    Am J Psychiatry; 1962 Apr 30; 118():934-5. PubMed ID: 14464348
    [No Abstract] [Full Text] [Related]

  • 15. Further studies with tranylcypromine (monamine oxidase inhibitor) and its interaction with reserpine in rat brain.
    GREEN H, ERICKSON RW.
    Arch Int Pharmacodyn Ther; 1962 Feb 01; 135():407-25. PubMed ID: 13901404
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of affective depression with trans-dl-phenylcyclopropylamine hydrochloride; a preliminary report.
    PETERSEN MC, McBRAYER JW.
    Am J Psychiatry; 1959 Jul 01; 116(1):67-8. PubMed ID: 13661454
    [No Abstract] [Full Text] [Related]

  • 17. [Experiences in the treatment of depressive states with 1-seryl-2-isopropylhydrazine].
    HEINRICH K.
    Psychiatr Neurol (Basel); 1960 Jul 01; 140():119-25. PubMed ID: 13712966
    [No Abstract] [Full Text] [Related]

  • 18. 3-Phenylcyclobutylamine.
    BURGER A, BENNETT R.
    J Med Pharm Chem; 1960 Dec 01; 2():687-91. PubMed ID: 13688995
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of depressive states with marplan.
    OLTMAN JE, FRIEDMAN S.
    Am J Psychiatry; 1960 Mar 01; 116():848-9. PubMed ID: 14428837
    [No Abstract] [Full Text] [Related]

  • 20. Effect of the combined administration of imipramine and a monoamine oxidase inhibitor.
    HIMWICH WA, PETERSEN JC.
    Am J Psychiatry; 1961 Apr 01; 117():928-9. PubMed ID: 13714420
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.